Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1
Authors: Löffler, D.; Welschof, M.; Goldmann, S. F.; Wölpl, A.
Source: European Journal of Immunogenetics, Volume 25, Number 5, October 1998 , pp. 339-347(9)
Abstract:MHC molecules present peptides in their binding groove to T-cell receptors inducing proliferation or cytotoxicity of alloreactive T cells. A previously generated human monoclonal antibody (mAb) UL-5 A1, recognizing a conformational epitope formed by HLA DR1/DRB1*0101 molecules and HLA-A2 derived peptides, demonstrates T-cell-like recognition of the peptide/MHC complex (PMC). To study the genes of the antigen binding region, the nucleotide sequences of the rearranged genes in the variable regions of UL-5 A1 were determined and the V-gene usage (VH3, Vλ2) was identified by comparison with published germlines. The genes encoding heavy (Fd) and light (L) chains of UL-5 A1 were linked and expressed in a bacterial system. Specificity of the recombinant Fab-5 A1 was determined with HLA-typed LCLs by flow cytometric analysis. As demonstrated in competitive inhibition assays, UL-5 A1 and Fab-5 A1 recognize the same PMC epitope on HLA-A2+, -DR1/DRB1*0101+ typed LCLs. Additionally, mAb UL-5 A1 and Fab-5 A1 both recognize HLA-A2–, -DR1/DRB1*0101+ LCLs exogenously loaded with HLA-A2 peptides (105–117, 103–117). UL-5 A1-like antibodies against peptide/MHC complexes could prove valuable tools for research on T-cell recognition and MHC function.
Document Type: Short Communication
Affiliations: Department of Transfusion Medicine, University Ulm, Department of Transplantation Immunology, Red Cross Blood Bank, Ulm, Germany, and German Cancer Research Centre, Heidelberg, Germany.
Publication date: October 1, 1998